Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis

By sjmartinez • February 28, 2023

Kuraji R, Shiba T, Dong TS, Numabe Y, Kapila YL. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis. World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967. PMID: 36844143; PMCID: PMC9950865.

Tags: Digestive Diseases, Dysbiosis, Metabolic syndrome, Microbiota, Nonalcoholic fatty liver disease, Periodontal disease, probiotics, Publications

Investigating shared genetic architecture between inflammatory bowel diseases and primary biliary cholangitis

Huang W, Jiang R, Li S, Zeng R, Li Y, Zhang Y, Tong S, Lyu Y, Wang J, Lian Q, Leung FW, Luo R, Sha[...]

Lower FIB-4 threshold in patients with diabetes improves diagnostic accuracy of the test in a Hispanic population

Singh J, Ibrahim B, Jackson NJ, Khalil H, Valenzuela J, Yanny B, Saab S. Lower FIB-4 threshold in patients with diabetes improves diagnostic accuracy of[...]

Role of the prefrontal cortical protease TACE/ADAM17 in neurobehavioral responses to chronic stress during adolescence

Sharafeddin F, Sierra J, Ghaly M, Simon TB, Ontiveros-Ángel P, Edelbach B, Febo M, Labus J, Figueroa JD. Role of the prefrontal cortical protease TACE/ADAM17[...]